Summit Therapeutics (SMMT) had the highest return in Q3 2024 by a large-cap US stock, returning 179.3%.
| ASSET | QUARTER | % RETURN |
|---|---|---|
Summit Therapeutics (SMMT) | Q3 2024 | 179.34% |
Aurora Innovation (AUR) | Q3 2024 | 114.49% |
Rocket Lab USA (RKLB) | Q3 2024 | 103.56% |
Xpeng (XPEV) | Q3 2024 | 63.27% |
EXACT Sciences (EXAS) | Q3 2024 | 61.38% |
Doximity (DOCS) | Q3 2024 | 55.61% |
BeiGene (ONC) | Q3 2024 | 55.59% |
JD Inc Adr (JD) | Q3 2024 | 54.26% |
Applovin (APP) | Q3 2024 | 53.37% |
Ubiquiti Networks (UI) | Q3 2024 | 52.33% |
Vaxcyte (PCVX) | Q3 2024 | 51.49% |
GE Vernova LLC (GEV) | Q3 2024 | 49.11% |
Erie Indemnity (ERIE) | Q3 2024 | 48.73% |
BioNTech SE (BNTX) | Q3 2024 | 48.06% |
VF (VFC) | Q3 2024 | 46.91% |
Alibaba (BABA) | Q3 2024 | 46.35% |
Palantir Technologies Inc Class A Common Stock (PLTR) | Q3 2024 | 46% |
Futu (FUTU) | Q3 2024 | 44.97% |
Yum China (YUMC) | Q3 2024 | 44.52% |
SharkNinja (SN) | Q3 2024 | 44.31% |
Samsara (IOT) | Q3 2024 | 43.21% |
Grupo Financiero Galicia SA ADR (GGAL) | Q3 2024 | 42.93% |
Klaviyo (KVYO) | Q3 2024 | 42.66% |
Liberty Broadband Srs C (LBRDK) | Q3 2024 | 42.52% |
Liberty Broadband Srs A (LBRDA) | Q3 2024 | 41.58% |
Large-cap stocks are treated as having a market cap of $10B+.
